Regulatory Hurdles for Increased Availability of Cannabis-Infused Edibles



Merril Gilbert, founder and CEO of TraceTrust: One is getting it declassified as a Schedule I narcotic. It’s clearly not that. There is no addictive qualities: it’s a combination of other things. But it’s also, again, how do I counteract it and not knowing how it’s going to react for different people. You’re going to have the same reaction as if you have a peanut allergy and we have to be really conscious of that. So, again, creating a standard like we’re doing in this same manner and together with other types of certifications –nonGMO and vegan– and really aligning together, raising up together and not competing against each other is crucial now.


For editorial opportunities:

Jennifer Barrett, Senior Editor

Gabrielle Ientile, Assistant Editor

For advertising opportunities:

William Mulderry, VP, Group Publisher

Eric Temple-Morris, VP, Healthcare

William Culberson, National Accounts Manager

Lauren Ruperto, National Accounts Manager

Powered by Medstro